Skip Ribbon Commands
Skip to main content

My child has

Because childhood should be simple ...

Marcela D. Torres, MD
Cook Children's Physician Network

Marcela D. Torres
Education:University Peruana Cayetano, Peru
Residency:Children's Hospital of Wisconsin
Fellowship:Children's Hospital of Wisconsin
Board Certified:Pediatrics and Pediatric Hematology/Oncology

Dr. Marcela Torres decided that her vocation in life was to become a doctor when she was only 15 years old. She started her studies in Medicine at the age of 17 years back in her country of origin, Peru. There she was exposed to all kinds of clinical challenges in the face of sparse resources, which helped her clinical skills tremendously. After finishing medical school she decided to come to the USA to do her residency in Pediatrics. At Children's Hospital of Milwaukee she quickly became interested in their Bone Marrow Transplant Program which was a pioneer in Unrelated T cell depleted bone marrow transplants in the nation.  But as she started her fellowship in Pediatric Hematology Oncology, she realized that her main interest was Hematology. Training in a national referral center for patients with Bleeding and Clotting disorders and doing her research at the nationally renowned Blood Center of Wisconsin, prepared her way to become an expert in this field. At the end of her fellowship, she had completed her research on Multimerin, a little known clotting protein. She was the recipient of the ASH Travel Award for poster entitled, "Recombinant  Multimerin and Factor V co-localize in Storage Granules in AtT-20 Cells"

She started to work at Cook Children's Hematology Oncology center back in the year 2000 and gradually her expertise and knowledge in bleeding and clotting disorders have allowed the growth of the Hematology section within the practice. She has also been involved in the twinning project with Peru sponsored by the WFH (World Federation of Hemophilia) and in 2006 our center was granted the Hemophilia Treatment Center Twin of the Year Award by the WFH. In addition, she continues to participate in several clinical research studies within the Hematology field.

At this point in time, she directs the Thrombosis and Stroke Programs which continue to grow at our institution. She is a member of the Hemostasis and Thrombosis Research Society, American Society of Hematology, International Society of Thrombosis and Hemostasis, International Pediatric Stroke Society and American Heart Association.


1500 Cooper St.
Fort Worth, TX 76104
(682) 885-4007
Driving directions


Aledort, L. M., Boggio, L., Davis, J. A., Gauger, C., Kobrinsky, N. L., Rajasekhar, A., Shapiro, R., TORRES, M., & Ulsh, P. J. (2015). Congenital thrombotic thrombocytopenia purpura-safer treatment with plasma-derived viral-attenuated clotting factor. Blood, 126(23), 3459.

Goldenberg, N. A., Abshire, T., Blatchford, P. J., Fenton, L. Z., Halperin, J. L., Hiatt, W. R., Kessler, C. M., Kittelson, J. M., Manco-Johnson, M. J., Spyropoulos, A. C., Steg, P. G., Stence, N. V., Turpie, A. G. G., Schulman, S., Punzalan, R., Wang, M., Jaffray, J., Young, G., Rajpurkar, M., Carpenter, S., Diab, Y., Verdun, N., Tarango, C., Acharya, S., TORRES, M., Kucine, N., Mitchell, B., Shah, N., Thornburg, C., Takemoto, C., Kulkarni, R., O'Brien, S., Haley, K., Recht, M., Knoll, C., Thornburg, C., Geddis, A., Ahuja, S., Simpson, M., Srivaths, L., Journeycake, J., & Zia, A. (2015). Multicenter randomized controlled trial on duration of therapy for thrombosis in children and young adults (the kids-DOTT trial): Pilot/feasibility phase findings. Journal of Thrombosis and Haemostasis, 13(9), 1597-1605.

Bernard, T. J., Rivkin, M. J., Scholz, K., deVeber, G., Kirton, A., Gill, J. C., Chan, A. K., Hovinga, C. A., Ichord, R. N., Grotta, J. C., Jordan, L. C., Benedict, S., Friedman, N. R., Dowling, M. M., Elbers, J., TORRES, M., Sultan, S., Cummings, D. D., Grabowski, E. F., McMillan, H. J., Beslow, L. A., Amlie-Lefond, C., & on behalf of the Thrombolysis in Pediatric Stroke Study. (2014). Emergence of the primary pediatric stroke center: Impact of the thrombolysis in pediatric stroke trial. Stroke; a Journal of Cerebral Circulation, 45(7), 2018-2023.

Leissinger, C., Josephson, C. D., Granger, S., Konkle, B. A., Kruse-Jarres, R., Ragni, M. V., Journeycake, J. M., Valentino, L., Key, N. S., Gill, J. C., McCrae, K. R., Neufeld, E. J., Manno, C., Raffini, L., Saxena, K., TORRES, M., Marder, V., Bennett, C. M., & Assmann, S. F. (2014). Rituximab for treatment of inhibitors in haemophilia A. A phase II study. Thrombosis and Haemostasis, 112(3), 445-458.

Vichinsky, E., TORRES, M., Minniti, C. P., Barrette, S., Habr, D., Zhang, Y., & Files, B. (2013). Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two-year results including pharmacokinetics and concomitant hydroxyurea. American Journal of Hematology, 88(12), 1068-1073.

Leissinger, C. A., Kruse-Jarres, R., Granger, S., Konkle, B. A., Ragni, M. V., Journeycake, J. M., Neufeld, E. J., Josephson, C., Bennett, C. M., Valentino, L. A., Key, N. S., Raffini, L., TORRES, M., Gill, J. C., & Assmann, S. (2011). Phase II trial of rituximab in the treatment of inhibitors in congenital hemophilia a: Results of the rich study. Blood, 118(21), 27.

Vichinsky, E., TORRES, M., Glass, J., Minniti, C. P., Barrette, S., Habr, D., Lynch, N., Zhang, Y., & Files, B. (2011). A randomized phase II study evaluating the efficacy and safety of deferasirox versus deferoxamine in patients with sickle cell disease (SCD): 2-year results including pharmacokinetics (PK) and safety of deferasirox with concomitant hydroxyurea therapy. Blood, 118(21), 1082. 

Kurth, M. A., Dimichele, D., Sexauer, C., SANDERS, J. M., TORRES, M., ZAPPA, S. C., Ragni, M., & Leonard, N. (2008). Immune tolerance therapy utilizing factor VIII/von willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors. Haemophilia : The Official Journal of the World Federation of Hemophilia, 14(1), 50-55.

Powell, K. K., Perdue, K. M., TORRES, M. D., Lockhart, S., Blanchong, C. A. (2008). Anatomic distribution of childhood deep venous thrombosis: An interim analysis of the HTRS TE registry. 21st Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO), Cincinnati, OH. May 14-17, 2008

TORRES, M., Van Tuinen, P., & Kroner, P. A. (2000). The human multimerin gene MMRN maps to chromosome 4q22. Cytogenetics and Cell Genetics, 88(3-4), 275-277.

TORRES, M., Kaufman, R. J., & Kroner, P. A. (1999). Recombinant multimerin and factor V co-localize in storage granules in AtT-20 cells. 40th Annual Meeting of the American Society of Hematology, Miami Beach, FL. December 4-8, 1998

Curtis, B. R., Ebert, D. D., TORRES, M., & Aster, R. H. (1998). Prolonged severe neutropenia in an infant due to high-titer NA2 alloantibody. 5th European Symposium on Platelet and Granulocyte Immunobiology, S'Agaro, Girona, Spain. May 9-12, 1998

TORRES, M., VanTuinen, P., Kroner, P. A., & Montgomery, R. R. (1998). The human multimerin gene maps to chromosome 4q22. 11th Annual Meeting of the American Society of Pediatric Hematology/Oncology, Chicago, IL. September 10-12, 1998, 20(4) 386.

Rocket Fuel